Back

A spatiotemporal atlas of orchiectomy-induced androgen deprivation-mediated modulation of cellular composition and gene expression in the mouse prostate.

Shelley, G.; May, A. M.; Robinson, T.; Dai, J.; Pitchiaya, S.; Keller, E. T.

2025-07-17 cancer biology
10.1101/2025.07.11.664414 bioRxiv
Show abstract

Androgen deprivation therapy (ADT) remains a cornerstone in the treatment of prostate cancer (PCa), yet most tumors eventually develop resistance. Murine models are widely used to study PCa progression and ADT response, but a detailed understanding of the prostates biological response to androgen deprivation in these models is lacking. Here, we present a comprehensive spatiotemporal analysis of cellular and transcriptional dynamics in the mouse prostate following orchiectomy (ORX)-induced androgen deprivation. We observed progressive involution across all prostate lobes (dorsal, ventral, lateral, and anterior) and distinct lobe-specific temporal gene expression changes post-ORX. Immune cell infiltration markedly increased over time, highlighting a shift in the prostates cellular landscape. Single-cell RNA sequencing uncovered a previously undescribed fibroblast subtype--termed ORX-induced fibroblast (OIF)-- characterized by high expression of Wnt2, Rorb, and Wif1, with distinct spatial localization. Pathway analysis revealed upregulation of amide and peptide binding functions, alongside suppression of peptidase and endopeptidase activity. Furthermore, dynamic changes in ligand-receptor interactions across lobes underscored the evolving intercellular communication in the post-ORX prostate. By integrating spatial transcriptomics with single-cell profiling, our study generates a high-resolution atlas of the murine prostates response to androgen deprivation. These findings provide a foundational resource for interpreting ADT responses in preclinical models of PCa.

Matching journals

The top 4 journals account for 50% of the predicted probability mass.

1
The Prostate
11 papers in training set
Top 0.1%
37.4%
2
PLOS ONE
5266 papers in training set
Top 21%
8.1%
3
The Journal of Pathology
26 papers in training set
Top 0.1%
4.5%
4
Molecular Cancer Research
49 papers in training set
Top 0.2%
4.5%
50% of probability mass above
5
eLife
5828 papers in training set
Top 28%
4.2%
6
Scientific Reports
3612 papers in training set
Top 28%
3.6%
7
American Journal of Physiology-Renal Physiology
28 papers in training set
Top 0.2%
2.5%
8
iScience
1154 papers in training set
Top 12%
2.2%
9
Cancers
213 papers in training set
Top 3%
1.7%
10
PLOS Genetics
862 papers in training set
Top 7%
1.7%
11
Cell Reports
1498 papers in training set
Top 21%
1.5%
12
Nature Communications
5641 papers in training set
Top 50%
1.2%
13
Neoplasia
23 papers in training set
Top 0.5%
1.2%
14
Cancer Research
130 papers in training set
Top 2%
1.2%
15
Cells
249 papers in training set
Top 4%
1.2%
16
Matrix Biology Plus
10 papers in training set
Top 0.1%
1.0%
17
Modern Pathology
22 papers in training set
Top 0.4%
0.9%
18
Communications Biology
993 papers in training set
Top 28%
0.9%
19
Journal of Translational Medicine
57 papers in training set
Top 2%
0.9%
20
Biology of Sex Differences
32 papers in training set
Top 0.5%
0.9%
21
JCI Insight
277 papers in training set
Top 7%
0.9%
22
Genome Biology
637 papers in training set
Top 9%
0.6%
23
Frontiers in Oncology
103 papers in training set
Top 3%
0.6%
24
Proceedings of the National Academy of Sciences
2444 papers in training set
Top 43%
0.6%
25
Cancer Research Communications
51 papers in training set
Top 2%
0.5%
26
The FASEB Journal
194 papers in training set
Top 7%
0.5%
27
Endocrinology
43 papers in training set
Top 0.9%
0.5%
28
Breast Cancer Research
36 papers in training set
Top 0.7%
0.5%
29
International Journal of Molecular Sciences
494 papers in training set
Top 19%
0.5%